In the test cohort, 56 (36.8%) of 152 patients with NSCLC were stage I. The relative expression levels of ITGA2B and SELP mRNA remained improved when only stage I lung cancer detection was involved (p < 0.001, Figure 3). The gene discussed is ITGA2B; the disease is lung cancer.